$2.26 Billion is the total value of Eventide Asset Management's 134 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 25.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ASND | Buy | ASCENDIS PHARMA A Ssponsored adr | $106,420,000 | -2.8% | 1,698,648 | +10.0% | 4.71% | +17.2% |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $92,233,000 | -7.9% | 845,168 | +36.3% | 4.08% | +11.0% |
| SAGE | Buy | SAGE THERAPEUTICS INC | $89,659,000 | +28.5% | 936,000 | +89.5% | 3.97% | +54.9% |
| SEND | Sell | SENDGRID INC | $77,404,000 | +6.9% | 1,793,000 | -8.9% | 3.43% | +28.8% |
| ZGNX | Buy | ZOGENIX INC | $62,456,000 | +6.4% | 1,713,000 | +44.7% | 2.76% | +28.2% |
| SPLK | Buy | SPLUNK INC | $59,135,000 | +8.0% | 564,000 | +24.5% | 2.62% | +30.2% |
| PANW | Buy | PALO ALTO NETWORKS INC | $56,693,000 | +21.0% | 301,000 | +44.7% | 2.51% | +45.8% |
| TTD | Buy | THE TRADE DESK INC | $55,825,000 | +2.8% | 481,000 | +33.6% | 2.47% | +23.9% |
| LOW | LOWES COS INC | $52,183,000 | -19.6% | 565,000 | 0.0% | 2.31% | -3.0% | |
| W | Buy | WAYFAIR INCcl a | $46,371,000 | -21.5% | 514,777 | +28.7% | 2.05% | -5.3% |
| XPO | XPO LOGISTICS INC | $44,948,000 | -50.0% | 788,000 | 0.0% | 1.99% | -39.8% | |
| HUBS | HUBSPOT INC | $44,006,000 | -16.7% | 350,000 | 0.0% | 1.95% | +0.4% | |
| AIMT | AIMMUNE THERAPEUTICS INC | $41,597,000 | -12.3% | 1,739,000 | 0.0% | 1.84% | +5.7% | |
| FIVN | FIVE9 INC | $39,086,000 | +0.1% | 894,000 | 0.0% | 1.73% | +20.6% | |
| WCN | WASTE CONNECTIONS INC | $38,387,000 | -6.9% | 517,000 | 0.0% | 1.70% | +12.1% | |
| LOXO | Buy | LOXO ONCOLOGY INC | $38,379,000 | -1.9% | 274,000 | +19.7% | 1.70% | +18.2% |
| COLL | COLLEGIUM PHARMACEUTICAL INC | $37,905,000 | +16.5% | 2,207,610 | 0.0% | 1.68% | +40.4% | |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $36,953,000 | -38.7% | 223,000 | -28.8% | 1.64% | -26.2% |
| MYOV | Buy | MYOVANT SCIENCES LTD | $36,179,000 | -35.6% | 2,204,708 | +4.2% | 1.60% | -22.3% |
| VRNS | Sell | VARONIS SYS INC | $34,491,000 | -35.4% | 652,000 | -10.6% | 1.53% | -22.1% |
| NEP | Sell | NEXTERA ENERGY PARTNERS LP | $34,053,000 | -12.2% | 791,000 | -1.1% | 1.51% | +5.9% |
| CCI | Sell | CROWN CASTLE INTL CORP NEW | $32,589,000 | -4.0% | 300,000 | -1.6% | 1.44% | +15.7% |
| LII | Buy | LENNOX INTL INC | $31,516,000 | +22.3% | 144,000 | +22.0% | 1.40% | +47.5% |
| LRCX | LAM RESEARCH CORP | $30,911,000 | -10.2% | 227,000 | 0.0% | 1.37% | +8.1% | |
| INST | INSTRUCTURE INC | $30,225,000 | +6.0% | 805,796 | 0.0% | 1.34% | +27.7% | |
| KAR | KAR AUCTION SVCS INC | $29,109,000 | -20.1% | 610,000 | 0.0% | 1.29% | -3.6% | |
| ROP | Buy | ROPER TECHNOLOGIES INC | $28,251,000 | +9.6% | 106,000 | +21.8% | 1.25% | +32.2% |
| MGA | MAGNA INTL INC | $27,893,000 | -13.5% | 613,700 | 0.0% | 1.24% | +4.3% | |
| ALTR | ALTAIR ENGR INC | $27,580,000 | -36.5% | 1,000,000 | 0.0% | 1.22% | -23.5% | |
| BLUE | BLUEBIRD BIO INC | $27,538,000 | -32.1% | 277,603 | 0.0% | 1.22% | -18.1% | |
| WBC | WABCO HLDGS INC | $27,436,000 | -9.0% | 255,600 | 0.0% | 1.22% | +9.8% | |
| ASML | Buy | ASML HOLDING N V | $26,922,000 | -16.8% | 173,000 | +0.6% | 1.19% | +0.3% |
| ARGX | Sell | ARGENX SEsponsored adr | $24,402,000 | -4.0% | 254,000 | -24.2% | 1.08% | +15.8% |
| STLD | STEEL DYNAMICS INC | $22,650,000 | -33.5% | 754,000 | 0.0% | 1.00% | -19.8% | |
| LEA | LEAR CORP | $22,606,000 | -15.3% | 184,000 | 0.0% | 1.00% | +2.1% | |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $22,211,000 | +0.9% | 412,000 | +46.1% | 0.98% | +21.7% |
| MNTA | Buy | MOMENTA PHARMACEUTICALS INC | $21,787,000 | +14.3% | 1,973,461 | +172.2% | 0.96% | +37.9% |
| QURE | Buy | UNIQURE NV | $21,218,000 | +2.3% | 736,209 | +29.2% | 0.94% | +23.4% |
| IMMU | Buy | IMMUNOMEDICS INC | $20,149,000 | +38.4% | 1,412,000 | +102.0% | 0.89% | +66.7% |
| TWLO | New | TWILIO INCcl a | $19,646,000 | – | 220,000 | +100.0% | 0.87% | – |
| MIC | Sell | MACQUARIE INFRASTRUCTURE COR | $19,596,000 | -58.7% | 536,000 | -47.9% | 0.87% | -50.2% |
| PEGI | Sell | PATTERN ENERGY GROUP INCcl a | $19,458,000 | -8.1% | 1,045,000 | -1.9% | 0.86% | +10.8% |
| MTD | Buy | METTLER TOLEDO INTERNATIONAL | $19,230,000 | +8.9% | 34,000 | +17.2% | 0.85% | +31.1% |
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $18,231,000 | +65.1% | 493,000 | +67.7% | 0.81% | +99.3% |
| IPHI | INPHI CORP | $17,843,000 | -15.4% | 555,000 | 0.0% | 0.79% | +2.1% | |
| KALV | KALVISTA PHARMACEUTICALS INC | $17,775,000 | -10.7% | 900,000 | 0.0% | 0.79% | +7.7% | |
| PAYC | Buy | PAYCOM SOFTWARE INC | $17,265,000 | +15.7% | 141,000 | +46.9% | 0.76% | +39.4% |
| AY | ATLANTICA YIELD PLC | $16,974,000 | -4.8% | 866,000 | 0.0% | 0.75% | +14.7% | |
| ICPT | New | INTERCEPT PHARMACEUTICALS IN | $16,933,000 | – | 168,000 | +100.0% | 0.75% | – |
| APTV | Buy | APTIV PLC | $16,892,000 | -25.3% | 274,350 | +1.8% | 0.75% | -10.0% |
| STKL | SUNOPTA INC | $16,643,000 | -47.3% | 4,300,540 | 0.0% | 0.74% | -36.5% | |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS IN | $15,065,000 | +72.4% | 367,000 | +59.6% | 0.67% | +107.8% |
| AVRO | AVROBIO INC | $14,901,000 | -67.9% | 928,891 | 0.0% | 0.66% | -61.3% | |
| MGTA | Buy | MAGENTA THERAPEUTICS INC | $14,814,000 | -43.6% | 2,650,808 | +18.4% | 0.66% | -32.0% |
| MYOK | MYOKARDIA INC | $14,756,000 | -25.1% | 302,000 | 0.0% | 0.65% | -9.7% | |
| ANET | Buy | ARISTA NETWORKS INC | $14,496,000 | -17.4% | 68,800 | +4.2% | 0.64% | -0.3% |
| TLND | New | TALEND S Aads | $14,388,000 | – | 388,033 | +100.0% | 0.64% | – |
| VKTX | Buy | VIKING THERAPEUTICS INC | $13,441,000 | -2.3% | 1,757,000 | +122.4% | 0.60% | +17.8% |
| HASI | Sell | HANNON ARMSTRONG SUST INFR C | $13,297,000 | -17.6% | 698,000 | -7.2% | 0.59% | -0.7% |
| PFPT | PROOFPOINT INC | $13,242,000 | -21.2% | 158,000 | 0.0% | 0.59% | -5.0% | |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $12,799,000 | +51.2% | 1,336,000 | +90.9% | 0.57% | +82.3% |
| CRUS | CIRRUS LOGIC INC | $12,277,000 | -14.0% | 370,000 | 0.0% | 0.54% | +3.6% | |
| VCYT | Sell | VERACYTE INC | $11,699,000 | -42.6% | 930,000 | -56.4% | 0.52% | -30.7% |
| NBIX | NEUROCRINE BIOSCIENCES INC | $11,140,000 | -41.9% | 156,000 | 0.0% | 0.49% | -30.0% | |
| STRO | SUTRO BIOPHARMA INC | $10,904,000 | -39.9% | 1,244,895 | 0.0% | 0.48% | -27.5% | |
| VMC | VULCAN MATLS CO | $10,868,000 | -11.2% | 110,000 | 0.0% | 0.48% | +7.1% | |
| RCKT | Buy | ROCKET PHARMACEUTICALS INC | $10,501,000 | +8.1% | 708,600 | +79.6% | 0.46% | +30.3% |
| STML | STEMLINE THERAPEUTICS INC | $10,321,000 | -42.8% | 1,086,400 | 0.0% | 0.46% | -31.0% | |
| IFRX | INFLARX NV | $10,002,000 | +6.0% | 275,000 | 0.0% | 0.44% | +27.7% | |
| WTRH | New | WAITR HLDGS INC | $9,767,000 | – | 876,000 | +100.0% | 0.43% | – |
| KNSA | KINIKSA PHARMACEUTICALS LTD | $8,961,000 | +10.2% | 319,000 | 0.0% | 0.40% | +32.8% | |
| BCRX | BIOCRYST PHARMACEUTICALS | $8,449,000 | +5.8% | 1,047,000 | 0.0% | 0.37% | +27.6% | |
| CTAS | New | CINTAS CORP | $8,400,000 | – | 50,000 | +100.0% | 0.37% | – |
| EXAS | EXACT SCIENCES CORP | $8,266,000 | -20.1% | 131,000 | 0.0% | 0.37% | -3.7% | |
| ARYAU | New | ARYA SCIENCES ACQUISITION COunit 10/04/2023 | $8,192,000 | – | 800,000 | +100.0% | 0.36% | – |
| DOOR | MASONITE INTL CORP NEW | $7,621,000 | -30.1% | 170,000 | 0.0% | 0.34% | -15.8% | |
| XNCR | Sell | XENCOR INC | $7,340,000 | -17.4% | 203,000 | -11.0% | 0.32% | -0.3% |
| EXR | EXTRA SPACE STORAGE INC | $7,238,000 | +4.4% | 80,000 | 0.0% | 0.32% | +25.5% | |
| WVE | WAVE LIFE SCIENCES LTD | $7,164,000 | -15.9% | 170,400 | 0.0% | 0.32% | +1.3% | |
| RARX | RA PHARMACEUTICALS INC | $7,062,000 | +0.6% | 388,000 | 0.0% | 0.31% | +21.3% | |
| THOR | New | SYNTHORX INC | $6,952,000 | – | 400,000 | +100.0% | 0.31% | – |
| MDCO | New | MEDICINES CO | $6,412,000 | – | 335,000 | +100.0% | 0.28% | – |
| GWPH | GW PHARMACEUTICALS PLCads | $6,184,000 | -43.6% | 63,500 | 0.0% | 0.27% | -32.0% | |
| BOLD | AUDENTES THERAPEUTICS INC | $5,863,000 | -46.1% | 275,000 | 0.0% | 0.26% | -35.0% | |
| RGEN | REPLIGEN CORP | $5,801,000 | -4.9% | 110,000 | 0.0% | 0.26% | +14.7% | |
| XLRN | ACCELERON PHARMA INC | $5,614,000 | -23.9% | 128,900 | 0.0% | 0.25% | -8.1% | |
| FENC | Sell | FENNEC PHARMACEUTICALS INC | $4,594,000 | -24.4% | 720,000 | -2.9% | 0.20% | -9.0% |
| UROV | Buy | UROVANT SCIENCES LTD | $4,409,000 | -38.2% | 669,000 | +12.5% | 0.20% | -25.6% |
| ORTX | New | ORCHARD THERAPEUTICS PLCads | $4,247,000 | – | 270,000 | +100.0% | 0.19% | – |
| VYGR | Sell | VOYAGER THERAPEUTICS INC | $4,098,000 | -69.2% | 436,000 | -38.0% | 0.18% | -63.0% |
| PTCT | Sell | PTC THERAPEUTICS INC | $3,878,000 | -66.2% | 113,000 | -53.7% | 0.17% | -59.1% |
| CRNX | CRINETICS PHARMACEUTICALS IN | $3,696,000 | +4.7% | 123,225 | 0.0% | 0.16% | +26.2% | |
| GLPG | GALAPAGOS NVspon adr | $3,670,000 | -18.4% | 40,000 | 0.0% | 0.16% | -1.8% | |
| ADVM | New | ADVERUM BIOTECHNOLOGIES INC | $3,612,000 | – | 1,146,580 | +100.0% | 0.16% | – |
| ETTX | Buy | ENTASIS THERAPEUTICS HLDGS I | $3,481,000 | -57.2% | 879,541 | +13.8% | 0.15% | -48.5% |
| VBIV | VBI VACCINES INC | $2,960,000 | -33.9% | 1,850,000 | 0.0% | 0.13% | -20.1% | |
| ARQL | New | ARQULE INC | $2,953,000 | – | 1,066,000 | +100.0% | 0.13% | – |
| XENE | Buy | XENON PHARMACEUTICALS INC | $2,678,000 | -35.6% | 424,433 | +34.7% | 0.12% | -22.2% |
| GTTN | Sell | GTT COMMUNICATIONS INC | $2,673,000 | -86.0% | 112,991 | -74.4% | 0.12% | -83.2% |
| BEP | BROOKFIELD RENEWABLE PARTNERpartnership unit | $2,668,000 | -14.3% | 103,000 | 0.0% | 0.12% | +3.5% | |
| ABB | Buy | ABB LTDsponsored adr | $2,414,000 | -17.3% | 127,000 | +2.8% | 0.11% | 0.0% |
| DERM | DERMIRA INC | $2,401,000 | -34.1% | 334,000 | 0.0% | 0.11% | -20.9% | |
| FHB | Buy | FIRST HAWAIIAN INC | $2,116,000 | -16.2% | 94,000 | +1.1% | 0.09% | +1.1% |
| HMC | HONDA MOTOR LTD | $2,103,000 | -12.0% | 79,500 | 0.0% | 0.09% | +5.7% | |
| TSM | Sell | TAIWAN SEMICONDUCTOR MFG LTDsponsored adr | $2,104,000 | -19.9% | 57,000 | -4.2% | 0.09% | -4.1% |
| TERP | TERRAFORM PWR INC | $2,020,000 | -2.8% | 180,000 | 0.0% | 0.09% | +17.1% | |
| CBIO | CATALYST BIOSCIENCES INC | $1,941,000 | -26.8% | 246,000 | 0.0% | 0.09% | -11.3% | |
| JCI | Sell | JOHNSON CTLS INTL PLC | $1,735,000 | -20.0% | 58,500 | -5.6% | 0.08% | -3.8% |
| Buy | HANNON ARMSTRONG SUST INFR Cnote 4.125% 9/0 | $1,725,000 | +26.7% | 1,894,000 | +35.9% | 0.08% | +52.0% | |
| ETN | EATON CORP PLC | $1,655,000 | -20.8% | 24,100 | 0.0% | 0.07% | -5.2% | |
| MLHR | Buy | MILLER HERMAN INC | $1,588,000 | -8.1% | 52,500 | +16.7% | 0.07% | +11.1% |
| BG | Buy | BUNGE LIMITED | $1,534,000 | -21.7% | 28,700 | +0.7% | 0.07% | -5.6% |
| BDN | BRANDYWINE RLTY TRsh ben int new | $1,474,000 | -18.1% | 114,500 | 0.0% | 0.06% | -1.5% | |
| CCIPRA | CROWN CASTLE INTL CORP NEW6.875% con pfd a | $1,426,000 | -3.1% | 1,355 | 0.0% | 0.06% | +16.7% | |
| ARE | ALEXANDRIA REAL ESTATE EQ IN | $1,152,000 | -8.4% | 10,000 | 0.0% | 0.05% | +10.9% | |
| CVA | Buy | COVANTA HLDG CORP | $1,074,000 | -15.8% | 80,000 | +1.9% | 0.05% | +2.1% |
| EPIX | ESSA PHARMA INC | $1,012,000 | -32.3% | 481,970 | 0.0% | 0.04% | -18.2% | |
| ERIC | Sell | ERICSSONadr b sek 10 | $976,000 | -9.5% | 110,000 | -10.2% | 0.04% | +7.5% |
| SNSS | SUNESIS PHARMACEUTICALS INC | $942,000 | -79.2% | 2,265,455 | 0.0% | 0.04% | -74.7% | |
| Buy | DERMIRA INCnote 3.000% 5/1 | $930,000 | +59.2% | 1,200,000 | +71.4% | 0.04% | +95.2% | |
| GPMT | Sell | GRANITE PT MTG TR INC | $883,000 | -47.1% | 49,000 | -43.4% | 0.04% | -36.1% |
| PLD | PROLOGIS INC | $881,000 | -13.4% | 15,000 | 0.0% | 0.04% | +5.4% | |
| APU | AMERIGAS PARTNERS L Punit l p int | $835,000 | -36.0% | 33,000 | 0.0% | 0.04% | -22.9% | |
| LXP | LEXINGTON REALTY TRUST | $657,000 | -1.1% | 80,000 | 0.0% | 0.03% | +20.8% | |
| LPT | LIBERTY PPTY TRsh ben int | $649,000 | -0.9% | 15,500 | 0.0% | 0.03% | +20.8% | |
| WELL | Sell | WELLTOWER INC | $521,000 | -49.7% | 7,500 | -53.4% | 0.02% | -39.5% |
| VTR | Sell | VENTAS INC | $498,000 | -57.4% | 8,500 | -60.5% | 0.02% | -48.8% |
| PSA | PUBLIC STORAGE | $405,000 | +0.5% | 2,000 | 0.0% | 0.02% | +20.0% | |
| New | MEDICINES COnote 2.750% 7/1 | $379,000 | – | 500,000 | +100.0% | 0.02% | – | |
| ACORDA THERAPEUTICS INCnote 1.750% 6/1 | $333,000 | -2.1% | 400,000 | 0.0% | 0.02% | +25.0% | ||
| CWEN | Sell | CLEARWAY ENERGY INCcl c | $276,000 | -76.5% | 16,000 | -73.8% | 0.01% | -72.1% |
| CIG | Sell | COMPANHIA ENERGETICA DE MINAsp adr n-v pfd | $231,000 | -73.8% | 65,000 | -87.4% | 0.01% | -68.8% |
| HERCULES CAPITAL INCdbcv 4.375% 2/0 | $190,000 | -2.1% | 200,000 | 0.0% | 0.01% | +14.3% | ||
| NOK | New | NOKIA CORPsponsored adr | $146,000 | – | 25,000 | +100.0% | 0.01% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -4,000 | -100.0% | -0.01% | – |
| IR | Exit | INGERSOLL-RAND PLC | $0 | – | -7,400 | -100.0% | -0.03% | – |
| ALLK | Exit | ALLAKOS INC | $0 | – | -35,000 | -100.0% | -0.06% | – |
| DLPH | Exit | DELPHI TECHNOLOGIES PLC | $0 | – | -52,666 | -100.0% | -0.06% | – |
| SEP | Exit | SPECTRA ENERGY PARTNERS LP | $0 | – | -47,000 | -100.0% | -0.06% | – |
| SYRS | Exit | SYROS PHARMACEUTICALS INC | $0 | – | -150,000 | -100.0% | -0.07% | – |
| IOVA | Exit | IOVANCE BIOTHERAPEUTICS INC | $0 | – | -280,000 | -100.0% | -0.12% | – |
| MGNX | Exit | MACROGENICS INC | $0 | – | -147,000 | -100.0% | -0.12% | – |
| IRWD | Exit | IRONWOOD PHARMACEUTICALS INC | $0 | – | -192,000 | -100.0% | -0.13% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -62,000 | -100.0% | -0.20% | – |
| AGIO | Exit | AGIOS PHARMACEUTICALS INC | $0 | – | -75,000 | -100.0% | -0.21% | – |
| SUPN | Exit | SUPERNUS PHARMACEUTICALS INC | $0 | – | -130,000 | -100.0% | -0.24% | – |
| RARE | Exit | ULTRAGENYX PHARMACEUTICAL IN | $0 | – | -87,400 | -100.0% | -0.24% | – |
| CERN | Exit | CERNER CORP | $0 | – | -108,200 | -100.0% | -0.26% | – |
| MDGL | Exit | MADRIGAL PHARMACEUTICALS INC | $0 | – | -33,000 | -100.0% | -0.26% | – |
| INCY | Exit | INCYTE CORP | $0 | – | -115,000 | -100.0% | -0.29% | – |
| REGN | Exit | REGENERON PHARMACEUTICALS | $0 | – | -23,000 | -100.0% | -0.34% | – |
| CELG | Exit | CELGENE CORP | $0 | – | -120,000 | -100.0% | -0.39% | – |
| SGEN | Exit | SEATTLE GENETICS INC | $0 | – | -152,000 | -100.0% | -0.43% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -132,000 | -100.0% | -0.47% | – |
| SNA | Exit | SNAP ON INC | $0 | – | -92,000 | -100.0% | -0.62% | – |
| SLDB | Exit | SOLID BIOSCIENCES INC | $0 | – | -400,000 | -100.0% | -0.69% | – |
| ECYT | Exit | ENDOCYTE INC | $0 | – | -1,314,000 | -100.0% | -0.86% | – |
| ANAB | Exit | ANAPTYSBIO INC | $0 | – | -262,275 | -100.0% | -0.96% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-14
About Eventide Asset Management
Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.
The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.
The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.
Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.
Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LOWES COS INC | 43 | Q2 2024 | 3.2% |
| PALO ALTO NETWORKS INC | 43 | Q2 2024 | 3.6% |
| ASML HOLDINGS NV | 43 | Q2 2024 | 1.9% |
| REPLIGEN CORP | 43 | Q2 2024 | 0.5% |
| VERACYTE INC | 41 | Q2 2024 | 1.5% |
| NEUROCRINE BIOSCIENCES INC | 40 | Q3 2023 | 1.1% |
| LAM RESEARCH CORP | 38 | Q2 2024 | 3.4% |
| COLLEGIUM PHARMACEUTICAL INC | 37 | Q2 2024 | 2.6% |
| BLUEPRINT MEDICINES CORP | 36 | Q2 2024 | 1.3% |
| XPO LOGISTICS INC | 34 | Q1 2023 | 3.8% |
View Eventide Asset Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| 908 Devices Inc. | February 14, 2024 | 1,430,995 | 4.4% |
| Annexon, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
| Celldex Therapeutics, Inc. | February 14, 2024 | 3,630,013 | 6.6% |
| COLLEGIUM PHARMACEUTICAL, INC | February 14, 2024 | 2,630,478 | 8.1% |
| Freeline Therapeutics Holdings plcSold out | February 14, 2024 | 0 | 0.0% |
| Inozyme Pharma, Inc. | February 14, 2024 | 3,179,837 | 5.2% |
| Korro Bio, Inc. | February 14, 2024 | 546,325 | 6.8% |
| MARINUS PHARMACEUTICALS, INC. | February 14, 2024 | 4,529,997 | 8.3% |
| Mirum Pharmaceuticals, Inc. | February 14, 2024 | 2,693,581 | 5.8% |
| Praxis Precision Medicines, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
View Eventide Asset Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-27 |
| 13F-HR | 2024-08-13 |
| SC 13G/A | 2024-08-09 |
| 13F-HR | 2024-05-15 |
| 13F-HR/A | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Eventide Asset Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.